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Background: Sepsis in very low birth weight (VLBW) infants has been
associated with an increased risk of adverse developmental outcome. We
have identiﬁed abnormal heart rate characteristics (HRCs) that are
predictive of impending sepsis, and we have developed a summary measure
of an infant’s abnormal HRCs during the neonatal hospitalization that we
refer to as the cumulative HRC score (cHRC).
Objective: In this study, we tested the hypothesis that increasing cHRC is
associated with an increasing risk of adverse neurodevelopmental
outcome in VLBW infants.
Method: Data were collected on 65 VLBW infants whose HRCs were
monitored while in the neonatal intensive care unit and who were
examined at 12 to 18 months adjusted age. Using the Bayley Scale of
Infant Development-II, we identiﬁed delays in early cognitive function
(i.e., Mental Developmental Index <70) and psychomotor development
(i.e., Psychomotor Developmental Index <70). Cerebral palsy (CP) was
diagnosed using a standard neurological examination.
Result: Increasing cHRC score was associated with an increased risk of
CP (odds ratio per 1 standard deviation increase in cHRC: 2.6, 95%
conﬁdence limits: 1.42, 5.1) and delayed early cognitive development
[odds ratio: 2.3 (1.3; 4.3)]. These associations remain statistically
signiﬁcant when adjusted for major cranial ultrasound abnormality.
There was an association of increasing cHRC and delayed psychomotor
development, which did not reach statistical signiﬁcance [odds ratio: 1.7
(1.0, 3.0)].
Conclusion: Among VLBW infants, the cumulative frequency of
abnormal HRCs, which can be assessed non-invasively in the neonatal
intensive care unit, is associated with an increased risk of adverse
neurodevelopmental outcome.
Journal of Perinatology (2009) 29, 750–756; doi:10.1038/jp.2009.81;
published online 25 June 2009
Keywords: cerebral palsy; developmental delay; very low birth weight;
bayley scales of infant development; heart rate characteristics; heart rate
variability
Introduction
Very low birth weight (VLBW) infants are at a high risk for sepsis
1
and have an increased incidence of cerebral palsy (CP) and
developmental delay compared with full term infants.
2,3 Recent
studies indicate that sepsis and the systemic inﬂammatory
response syndrome (SIRS) are associated with an increased
risk for developmental impairments in infants born
prematurely.
4–6
We have reported that certain heart rate characteristics (HRCs),
speciﬁcally, transient decelerations, decreased variability, and a
lack of accelerations, can be used to identify infants who are at
increased risk for developing either sepsis or systemic inﬂammatory
response.
7–9 A summation of an infant’s abnormal HRC during
neonatal hospitalization, referred to as the cumulative HRC
(cHRC) index, is predictive of mortality.
10 In the current study, we
analyzed association between cHRC during the neonatal
hospitalization and neurodevelopmental outcome between 12 and
18 months corrected age. Our objective was to determine whether
an elevated cHRC is associated with adverse neurodevelopmental
outcome at 12 to 18 months corrected age.
Methods
This study was approved by the Wake Forest University Health
Sciences Institutional Review Board.
Study participants
Inclusion criteria for this study were as follows: (1) birth weight
<1500g; (2) admitted to the Wake Forest University Baptist
Medical Center Intensive Care Nursery between 1999 and 2001;
(3) evaluated at 12 months adjusted age at the Wake Forest
University Development Evaluation Clinic; (4) at least 12, 6-h
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www.nature.com/jpepochs of HRC monitoring available for analysis; (5) no major
congenital anomaly. The study was approved by the Wake Forest
University Baptist Medical Center Institutional Review Board with a
waiver of the requirement for informed consent.
Measurements
Collection of HRCs data
Heart rate data were collected non-invasively from the bedside
monitors used in routine care of infants in the Wake Forest
University Baptist Medical Center Intensive Care Nursery. Data were
collected continuously 24h a day without selection of epochs
relevant to sleep, feeding, clinical status, or any other factors.
Brieﬂy, an analog electrocardiographic signal is obtained from the
deﬁb-sync output port of the bedside monitor. This signal is
digitized at 4kHz by a microcomputer at the bedside. The
data are high-pass ﬁltered, and QRS complexes are identiﬁed
using amplitude and duration criteria to generate sets of RR
intervals. These sets of intervals are used to generate HRC
parameters including standard deviation, sample asymmetry,
and sample entropy analyses. These parameters are used as
inputs to a predictive model algorithm using a multivariable
logistic regression that was developed at the University of
Virginia and externally validated at Wake Forest University.
The output of the model is divided by the average risk of sepsis
and presented as the fold-increase in risk of sepsis in the
net 24h.
Calculation of HRCs
Sample asymmetry. Quadratic ‘risk-analysis’ functions are
calculated using raw data. Given a series of 4096 RR intervals x1,
x2, y x4096 with median¼m, we compute r1(xi)¼r(xi) if
xi<m; 0 otherwise, and r2(xi)¼r(xi) if xi>m; 0 otherwise. The
Left (R1) and Right (R2) HRC risks are:
R1 ¼
1
4096
X
4096
i¼1 r1ðxiÞ
2
and
R2 ¼
1
4096
X
4096
i¼1 r2ðxiÞ
2
respectively.
The parameters of interest are R1, which relates to the number
and extent of HR accelerations, R2, which similarly reports on
decelerations, and the ratio R2/R1, which we have called the
sample asymmetry.
11
Sample entropy. Sample entropy (SampEn) is calculated with
m¼3, r¼0.2 as described
12 using ﬁltered, normalized data. In
this context, reduced sample entropy occurs when both reduced
variability and transient decelerations are present.
13
Predictive multi-variable statistical models. These have the
form of regression expressions of the form:
probðY ¼ 1Þ¼
expðlogitðY ¼ 1ÞÞ
1 þ expðlogitðY ¼ 1ÞÞ
where:
logitðY ¼ 1Þ¼b0 þ b1HRC1 þ b2HRC2 þ ...þ bmHRCm
where HRCm are HRCs of interest.
Calculation of cHRC
The infant’s hospital stay was divided into 6h epochs. For each 6h
epoch, the infant was given a demographic index, calculated from
a logistic regression model containing the variables for gestational
age, birth weight, and days of age.
7 The infant was also given a
HRC index value for each 6h epoch, calculated from a different
logistic regression model using the HRCs as input variables. The
probability of sepsis or SIRS over the next 24h of the infant’s life
was the outcome variable used in both of these logistic regression
models. Therefore, the demographic index is the probability that
sepsis or systemic inﬂammatory response will occur within the next
24h as predicted only by the demographic variables and the HRC
index is the probability that sepsis or SIRS will occur within the
next 24h as predicted by the HRCs. The cHRC is calculated by
subtracting the demographic index from the HRC index for each
epoch, and then summing up all the epochs of the infant’s stay.
10
cHRC ¼
X
½ðHRCindexÞ ð DemographicindexÞ 
Therefore, the cHRC gives an overall picture of whether the
infant clinically did better or worse than expected for the average
infant based solely on knowing the birth weight and gestational
age. If the infant had a benign hospital course and did better than
expected, then the majority of the HRC index values would be low
and the cHRC would be less than zero. If the infant did poorly, with
multiple episodes of sepsis or SIRS, then the majority of the HRC
index values would be high and the cHRC would be greater than
zero. If the infant had a typical hospital course, then the cHRC
would be close to zero.
Patient characteristics
Data about birth weight, gestational age, gender, race, chronic
lung disease, and cranial ultrasound abnormalities were obtained
from an electronic database maintained at our follow-up clinic.
The data were abstracted from medical records by a study
coordinator who was not aware of the study hypothesis or the
infants’ cHRC score. Sepsis was deﬁned as a positive blood culture
treated with at least 7 days of antibiotics. Small for gestational age
was deﬁned as birth weight less than the 10th percentile for
gestational age, based on data reported by Alexander et al.
14
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oxygen at 36 weeks postmenstrual age.
15 Major cranial ultrasound
abnormalities were deﬁned as any of the following: (1)
periventricular echodensity located ipsilateral to a presumed
intraventricular hemorrhage (i.e., abnormal echodensity in the
ventricle); (2) posthemorrhagic hydrocephalus requiring
neurosurgical intervention; (3) moderate or severe ventricular
enlargement on a ‘late’ (performed after the ﬁrst month of life)
ultrasound; or (4) periventricular echolucency.
16
Developmental outcomes
Follow-up data were obtained at 12 (n¼58) or 18 (n¼7)
months adjusted age at the Wake Forest University Development
Evaluation Clinic. Children were classiﬁed as having CP or not by
a standardized neurological examination performed by physicians
who were aware of the patient’s medical history, but not aware of
the cHRC score. The Bayley Scales of Infant Development-Second
Edition (BSID-II)
17 was administered by child psychologists who
were not aware of the child’s medical history. After testing was
completed, the psychologists learned of the child’s gestational age
at birth to derive the BSID-II scores adjusted for gestational age.
CP was deﬁned as a non-progressive central nervous system
disorder characterized by abnormal muscle tone in at least one
extremity and abnormal control of movement and posture
resulting in impaired motor function.
18 Delayed early cognitive
development was deﬁned as a BSID-II Mental Development Index
(MDI) <70; delayed psychomotor development was deﬁned as a
Psychomotor Development Index (PDI) <70. We used the term
neurodevelopmental impairment to refer to a composite outcome
of either CP or a BSID MDI or PDI <70.
Data analysis
We analyzed associations between cHRC and developmental
outcome in several ways: (1) correlations between cHRC and MDI
and cHRC and PDI were analyzed using Spearman rank
correlation coefﬁcients; (2) infants were classiﬁed into cHRC
quartiles for each of the dichotomous outcomes of interest (i.e., CP,
delayed early cognitive and psychomotor development, a composite
outcome of CP or delayed early cognitive development) and the
resulting 2 4 contingency tables were analyzed using the
Cochran-Armitage test for trend.
19 (3) Logistic models were used to
estimate the odds ratios for the association of cHRC, entered as a
continuous variable, and the dichotomous outcomes of interest. To
compare groups of infants with and without each outcome of
interest, we used the Wilcoxon rank sum test for continuous
variables and the w
2 or Fisher’s exact test for categorical variables.
Multivariate analysis was performed using logistic regression.
Only variables that had a P-value <0.1 in the univariate analysis
were included in the logistic regression model. Variables with the
highest P-value were eliminated one at a time using stepwise
elimination until all variables within the model had adjusted
P-values <0.1. All statistical analysis was performed using SAS
version 9.1 (SAS Institute, Cary, NC.)
Results
The attributes of these infants are summarized in Table 1. The
median cHRC was 4.0, and the range was  4.9 to 43.5. cHRC was
inversely correlated with both MDI (Spearman’s rho¼ 0.29,
P¼0.02) and PDI (Spearman’s rho¼ 0.39, P¼0.001; data
not shown). The Cochran-Armitage test for trend showed a
statistically signiﬁcant linear trend between the quartiles for CP,
MDI <70, and the composite outcome of CP or MDI <70 (all
P-values <0.05; data not shown). cHRC was higher among infants
with sepsis (P¼0.002), but signiﬁcant associations were not found
between sepsis and any of the developmental outcomes of interest
(all P-values >0.1; data not shown).
Table 2 summarizes associations between infant characteristics
and the developmental outcomes of interest. At signiﬁcance level of
0.1, cHRC and major cranial ultrasound abnormality were
associated with each of the developmental outcomes that we
studied. Gestational age was associated with an increased risk of
CP, MDI <70, and birth weight was associated with MDI <70.
Chronic lung disease was associated with MDI <70, and
necrotizing enterocolitis was associated with PDI <70. Non-white
race was associated with an increased risk of CP.
Table 1 Characteristics and outcomes of study infants
Characteristic/outcome VLBW infants (n¼65)
Gestational age (weeks)
a 26 (22–33)
Birth weight (g)
a 792 (406–1470)
Small for gestational age 7 (11)
Race
White 37 (57)
Non-white 28 (43)
Female gender 36 (55)
Sepsis 46 (71)
Necrotizing enterocolitis 10 (15)
Chronic lung disease 34 (52)
Major ultrasound abnormality 17 (26)
cHRC
a 4.0 ( 4.9 to 43.5)
Cerebral palsy 10 (16)
b
MDI <70 11 (17)
PDI <70 27 (42)
NDI 16 (25)
Data are number of infants (percentage in parenthesis) except where noted.
aData are median (range in parenthesis).
bOne infant did not undergo neurological examination at follow-up.
Abbreviations: cHRC, cumulative heart rate characteristics index; MDI, Mental
Developmental Index; PDI, Psychomotor Developmental Index; NDI, neurodevelopmental
impairment.
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CP, PDI <70, and the composite outcome of CP or delayed early
cognitive development, only cHRC and major cranial ultrasound
abnormalities were retained when variables were eliminated in a
stepwise fashion using a <0.1 as the criteria for remaining in the
model. In analyses in which the outcome of interest was delayed
MDI <70, chronic lung disease was also signiﬁcant at P<0.1.
Unadjusted and adjusted odds ratios for a one standard deviation
increase in cHRC are presented in Table 3.
Discussion
In a sample of VLBW infants, we found that cHRC is correlated
with scores on the BSID-II and that the risk of CP increases with
increasing cHRC. These associations were attenuated only slightly
when adjusted for the presence of major abnormalities on cranial
ultrasound. Thus, cHRC is associated not only with mortality, as we
have described earlier, but also with developmental impairments
among VLBW. As would be expected, we found higher cHRC values
among infants who were diagnosed with sepsis. Although we did
not collect data about the occurrence of culture-negative sepsis, our
prior studies indicate that the HRCs that inﬂuence cHRC are found
in infants with both culture-positive and culture-negative sepsis.
9
The HRCs that determine cHRC have been associated with
impending neonatal sepsis, an event that may initiate a systemic
inﬂammatory response (SIRS), including increased levels of blood
cytokines.
20 A growing body of evidence suggests a link between
fetal and neonatal inﬂammation, increased blood levels of
inﬂammatory cytokines, and subsequent neurodevelopmental
impairments.
4–6,21 Although our results demonstrate an
association between cHRC and neurodevelopmental outcome, our
ﬁndings are in agreement with Vohr et al.,
22 in that we did not
ﬁnd an association between culture proven sepsis and adverse
neurodevelopmental outcome. Thus, elevated cHRC may be
indicative of not only culture proven sepsis, but other initiators of
inﬂammation, such as SIRS with negative cultures and necrotizing
enterocolitis.
White matter damage, as indicated by persistent ventricular
enlargement or cerebral echolucency on cranial ultrasound,
23 is
probably the strongest single predictor of CP
24,25 and delayed early
cognitive functioning
22,26 among VLBW infants. Experiments in
animal models
4,27 and observational studies in humans
28 suggest
that initiators of fetal and neonatal inﬂammation are associated
with neonatal white matter damage. Increased levels of
inﬂammatory cytokines have been detected in the amniotic ﬂuid of
infants who subsequently developed periventricular white matter
Table 2 Characteristics of VLBW infants with and without developmental impairments
Characteristic Cerebral palsy MDI <70 PDI <70
Absent (n¼54) Present (n¼10) Absent (n¼54) Present (n¼11) Absent (n¼38) Present (n¼27)
Gestational age (weeks) 27 (23–31) 25 (22–33)* 27 (22–33) 25 (23–29)* 26.5 (22–31) 26 (23–33)
Birth weight (g) 798 (440–1470) 725 (406–1470) 814 (440–1470) 650 (406–1439)* 798 (440–1470) 790 (406–1470)
Small for gestational age 5 (9) 2 (20) 5 (9) 2 (18) 2 (5) 5 (19)
Race
White 34 (63) 3 (30)* 31 (57) 6 (55) 21 (55) 16 (59)
Non-white 20 (37) 7 (70) 23 (43) 5 (45) 17 (45) 11 (41)
Female gender 31 (57) 4 (40) 29 (54) 7 (64) 21 (55) 15 (56)
Sepsis 37 (69) 8 (80) 37 (69) 9 (82) 24 (63) 22 (81)
Necrotizing enterocolitis 8 (15) 2 (20) 8 (15) 2 (18) 3 (8) 7 (26)*
Chronic lung disease 27 (50) 6 (60) 24 (44) 10 (91)* 18 (47) 16 (59)
Major Ultrasound abnormality 10 (19) 7 (70)* 11 (20) 6 (55)* 6 (16) 11 (41)*
cHRC 3.76
( 4.91 to 41.08)
18.14
( 1.61 to 43.48)*
 2.31
( 4.91 to 33.60)
9.20
( 1.61 to 43.48)*
2.05
( 4.91 to 22.06)
5.53
( 1.61 to 43.48)*
Data are medians (range in parenthesis) or number of infants (percentage in parenthesis). *P<0.1.
Abbreviation: cHRC, cumulative heart rate characteristics index.
Table 3 Multivariate analysis
Outcome OR (95% CI) P-value Adjusted OR (95% CI) P-value
Cerebral palsy 2.6 (1.4–5.1) 0.004 2.3 (1.2, 4.7)
a 0.02
MDI <70 2.3 (1.3–4.3) 0.007 2.1 (1.0, 4.2)
b 0.04
PDI <70 1.7 (1.0–3.0) 0.06 1.5 (0.9, 2.7)
a 0.1
NDI 3.3 (1.6–7.0) 0.002 3.0 (1.4, 6.6)
a 0.005
Odds ratios and 95% conﬁdence intervals for each 10 unit increase in cHRC.
aOR adjusted for head ultrasound results.
bOR adjusted for head ultrasound results and chronic lung disease.
Abbreviations: cHRC, cumulative heart rate characteristics index; OR, odds ratio; CI,
conﬁdence interval; MDI, Mental Developmental Index; PDI, Psychomotor Developmental
Index; NDI, neurodevelopmental impairment.
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29 The HRC index rises with sepsis,
9,30,31 when blood levels
of inﬂammatory cytokines would be expected to increase.
20 Thus,
an elevated cHRC score may be reporting on exposure to one of the
putative causes of brain damage in preterm infants.
Despite its usefulness in identifying brain damage, white matter
as seen on cranial ultrasound has been referred to as the ‘tip of the
iceberg’
32 because ultrasound fails to detect white matter damage
in a substantial proportion of affected infants.
33,34 This may
explain why almost 25% of extremely low birth weight infants with
developmental impairment have normal cranial ultrasound.
35 The
current study suggests that in addition to its potential as a means
of earlier identiﬁcation of impending sepsis,
7,9,31 HRC monitoring
might provide prognostic information that is to some degree
complementary to that provided by cranial ultrasound.
36,37
Somewhat similar approaches were used by Mattia and
deRegnier,
38 who found that the summation of the Severity of
Neonatal Acute Physiology scores was predictive of lower MDI and
PDI scores at 2 to 3 years of age, and Broitman et al.,
39 who found
that a multivariate index derived from clinical data were a better
predictor of developmental impairment than cranial ultrasound.
39
The association of cHRC with delayed psychomotor development
was weaker than that between cHRC and the other
neurodevelopmental outcomes that we studied. It is possible that
the reliability of our assessments of psychomotor development at
12 to 18 months adjusted age was lower than that of our
assessments of early cognitive development (with the MDI). A
second possibility is that the risk factor proﬁle differs for MDI <70
and PDI <70. For example, major cranial ultrasound abnormalities,
chronic lung disease and necrotizing enterocolitis are associated
more strongly with PDI <70 than with MDI <70.
22,40
The speciﬁc HRCs that we studied here have not been previously
analyzed in relation to neurodevelopmental outcomes. However,
others have studied the maturation of heart rate variability, which
is one of the variables that inﬂuences cHRC. In preterm infants,
greater heart rate variability at 40 weeks postmenstrual age was
found to be predictive of higher Bayley MDI,
41 and the rate
maturation of heart rate variability between 33 and 35 weeks
postmenstrual age has been correlated with better behavior
regulation at 3 years
42 and greater social competency at
6 to 9 years.
43
We should note that there are several limitations in our study;
most important is our relatively small convenience sample. All of
these infants were transported to a tertiary hospital and would,
therefore, be at high risk of developmental impairments. For
example, the prevalence of CP (16%) described here is higher than
that reported from population-based studies.
18,44 Second, this is a
retrospective analysis, which likely limited the validity of data about
potential confounders, such as cranial ultrasound ﬁndings,
limiting our ability to adjust for these confounders. We also had
limited information about socioeconomic status, which is
associated with performance on the BSID.
22 Third, although the
physicians who performed the neurological assessments were not
aware of infants’ cHRC, they were aware of the infant’s medical
history, which could have led to ascertainment bias if these
examiners suspected an association between events that increase
cHRC (such as neonatal sepsis) and subsequent developmental
impairments. Finally, examinations at 12 to 18 months adjusted
age are somewhat limited in their sensitivity for identiﬁcation of
CP
45 and delayed early cognitive functioning ability,
46 which may
have resulted in misclassiﬁcation of infants with respect to the
presence of developmental impairment. Before applying our
ﬁndings to the clinical care of patients, replication is needed in a
larger, and more representative sample of high-risk infants, with
data about potential confounders prospectively collected.
Despite these limitations, the results of our study support the
need for larger analyses of the relationship of neonatal cHRC score
to neurodevelopmental outcome. If an association of cHRC and
outcome is conﬁrmed in larger studies, more study of the
antecedents of cHRC would be warranted. Study is needed also of
the relationship between HR variability and known antecedents of
poor long-term outcome, such as necrotizing enterocolitis
47 and
chronic lung disease.
48 Research into the possible mechanisms
linking HRCs and developmental outcome should include
assessment of inﬂammatory cytokines and other biomarkers of
inﬂammation.
49
The data from which the cHRC is derived can be obtained
non-invasively with a commercially available device, but
modiﬁcation of the software programming in this device would be
needed to automate computation of the cHRC. The clinical utility
of continuous HRCs monitoring is currently under study
(ClinicalTrials.gov Identiﬁer: NCT00307333). At the present time,
we can only speculate as to the clinical utility of cHRC. cHRC
might add to the predictive information conveyed by cranial
ultrasound ﬁndings
24,37 and clinical data.
39 Improved prediction of
neurodevelopment impairment could allow clinicians to target
infants at highest risk so that early intervention could be initiated,
and outcome improved.
50
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